Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 9—September 2015
Dispatch

Disseminated Enteroviral Infection Associated with Obinutuzumab

Claire DendleComments to Author , Michael Gilbertson, Tony M. Korman, Vera Golder, Eric Morand, and Stephen Opat
Author affiliations: Monash Health, Clayton, Victoria, Australia (C. Dendle, M. Gilbertson, T.M. Korman, V. Golder, E. Morand, S. Opat); Monash University, Clayton (C. Dendle, T.M. Korman, V. Golder, E. Morand, S. Opat)

Main Article

Figure

Magnetic resonance image of 63-year-old woman in Australia with disseminated enteroviral infection that manifested after she received obinutuzumab for lymphoma. Image shows patient’s thighs and diffuse inflammatory changes involving subcutaneous tissues, fascia, and musculature.

Figure. Magnetic resonance image of 63-year-old woman in Australia with disseminated enteroviral infection that manifested after she received obinutuzumab for lymphoma. Image shows patient’s thighs and diffuse inflammatory changes involving subcutaneous tissues, fascia, and musculature.

Main Article

Page created: August 14, 2015
Page updated: August 14, 2015
Page reviewed: August 14, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external